I reiterate my 'Buy' rating on Docusign, with a fair value estimate of $95 per share, despite near-term billing growth deceleration. DOCU's international expansion and growing Intelligent Agreement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results